SKP2 and leukemia: In contrast, all Skp2−/− ICNns recipients developed leukemia and showed PB, BM, and tissue involvement similar to that observed in recipients of Skp2+/+ ICN cells; however, they exhibited a delayed onset of disease and slower kinetics of progression (Fig. 4c–e), which persisted in secondary transplants (Fig. S6D).